Page 3 - Pharmascience Inc News Today

SAINT LAURENT, Quebec, April 13, 2023 -- IntelGenx Technologies Corp.  today announced various changes to its management team. Following the planned retirement of its founder and CEO, Horst... | April 13, 2023

EQS-News: PAION AG / Key word: Annual Results PAION AG reports on fiscal year 2022 30.03.2023 / 07:30 CET/CEST The issuer is solely responsible for the content of this... | March 30, 2023

EQS-News: PAION AG / Key word(s): Annual Results PAION AG reports on fiscal year 2022 30.03.2023 / 07:30 CET/CEST The issue...

EQS-News: PAION AG / Key word(s): Annual ResultsPAION AG reports on fiscal year 2022 30.03.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement. PAION AG reports on fiscal year 2022 Combined revenues of EUR 33.2 million Cash and cash equivalents of EUR 10.6 million as of 3...

2022 was an active year in Canadian patent law. Claim fees were introduced for the first time; changes were made to regulations providing remedies for excessive pricing of patented...

Pharmascience Inc. voluntarily recalls one lot of pms-Atenolol 100mg due to a labelling error | The Laval News | Serving Laval Since 1993

Pharmascience Inc. is pleased to announce today the appointment of Martin Arès as Chief Executive Officer, effective January 3, 2023. This...

Delayed release tablets to treat ulcerative colitis launched in Canada by sufferers with highest number of cases

Cassels Brock Blackwell, Mindon Gross lead the way in Commercial List appearances this week

Historically, claim fees have not been payable at any time during the pendency of a Canadian patent application or term of the patent. This changed on October 3, 2022, and the present...